Announces 2024 reagent manufacturing plans
Diatron, a prominent player in the development, manufacturing, and marketing of haematology and clinical chemistry analysers and their associated reagents for medical and veterinary use, has taken a significant step by inaugurating a new office in New Delhi. This strategic move highlights Diatron’s commitment to strengthening its presence in Asia, a region with a burgeoning diagnostics market, and to providing its services to both existing and new customers in the Asia-Pacific (APAC) region. Additionally, the company plans to commence manufacturing its associated reagents for medical and veterinary use in India in 2024, a move that will create new job opportunities in India.
Diatron’s new office in India (Asia) marks a pivotal development, bringing numerous advantages to customers and partners alike. The establishment of a sales presence in the APAC region ensures swift and timely support, expediting project progress and leading to more efficient outcomes. Enhanced communication capabilities and geographical proximity promise to eliminate language barriers, fostering a more productive collaboration.
Peter Zsoka, CFO and Board of Director, Diatron, Budapest, Hungary, spoke about the Indian expansion project, saying, “We started this journey five years ago with a vision to expand our regional presence. The inauguration of our new office in Delhi marks a significant milestone. With the new office, we plan to further strengthen our commitment to the Indian market. Our goal is to commence reagent manufacturing in India by 2024, reflecting our dedication to this region and the healthcare sector.”
Ronald Backes, Vice President of Sales & Marketing & Board Member, Diatron, Budapest, Hungary, says, “We are dedicated to strengthening our partnership with the Asian market, a region that has always been of the utmost importance to us. The opening of our new office is a testament to our commitment to contributing to healthcare advancements. The early results and benefits we’ve witnessed are just the beginning of a long and prosperous partnership. Together, we aim to spearhead healthcare advancements in Asia, ultimately enhancing the quality of patients’ lives.”
Julio Freyre, Director, Clinical Chemistry Business, Diatron MI Plc. in Budapest, Hungary, expressed, “Expanding into the APAC region is a remarkable stride in our dedication to advancing global healthcare. We are determined to bolster the healthcare system in the region by offering innovative solutions and cutting-edge diagnostics. Our devoted team in India will play a pivotal role in realising this vision.”
For over three decades, Diatron has been on a dedicated journey with a singular purpose – to develop, manufacture, and distribute high-quality diagnostic equipment tailored to the healthcare sector. Their product range includes clinical chemistry and haematology analysers for human and veterinary use, designed to enhance medical diagnostics and patient care.
These systems play a crucial role in early disease detection, from diabetes and anaemia to cardiovascular conditions, through blood analysis. They enable doctors to promptly identify issues and initiate timely treatments, ultimately saving lives. Diatron’s vision has made its brand recognised globally, with products distributed and marketed in more than 110 countries. Over 50,000 Diatron clinical chemistry and haematology analysers are actively used in laboratories worldwide, and their continuous growth is attributed to strong customer relationships.
